🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary aim of this study is to clarify the position of FF and FF/Vilan...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-03-27
Trial ID
NCT02094937
A pooled analysis of three bioequivalence studies conducted for Fluticasone...
Status
Completed
Location
BECRO Clinical Facility
Start Date
2019-06-02
Trial ID
NCT04790838
The purpose of this study is to evaluate the site and mechanisms responsibl...
Status
Recruiting
Location
Arthur F Gelb Medical Corporation
Start Date
2007-10-25
Trial ID
NCT00576069
Treatments Being Tested
This is a multicenter study to evaluate the efficacy and safety of MK0476 v...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00284856
Treatments Being Tested
In the current study GSK961081 and fluticasone propionate will be administe...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-07-13
Trial ID
NCT01449799
This study will evaluate the effects of budesonide (using Symbicort which i...
Status
Unknown
Location
St. Paul's Hospital
Start Date
2015-02
Trial ID
NCT02833480
Treatments Being Tested
This is a randomized, multi-center, parallel-group, active-controlled, doub...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00394355
The purpose of this study is to determine whether patients with asthma who ...
Status
Completed
Location
Maternal and Child Health Sciences, Ninewells Hospital and Medical School
Start Date
2007-08
Trial ID
NCT00655616
Treatments Being Tested
To demonstrate the free combination of budesonide and indacaterol is as eff...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-05-30
Trial ID
NCT02055352
Treatments Being Tested
This purpose of this study is to show the superiority and long term safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05
Trial ID
NCT00452699
Treatments Being Tested